
    
      ILCs profiles, epithelium metabolism measured by VOCS and microbiome profiling (specific 16S
      rRNA-16S ribosomal RNA gene-targeted qPCR) will by determined in the airways of patients with
      COPD after the exacerbation. Microbiome profiling will be based on next generation sequencing
      (NGS) of the 16S rRNA encoding region.
    
  